Overview
5-Amino-1MQ is a small molecule, not a peptide. Experimental publications describe it among membrane-permeable inhibitors of nicotinamide N-methyltransferase, abbreviated NNMT, a cellular enzyme studied in metabolic research.
Each vial contains 10 mg of 5-Amino-1MQ. The product is supplied as research material only and is not presented as a medicine, supplement or product for human or animal use.
Mechanism and research
NNMT catalyses the methylation of nicotinamide. It is therefore investigated in connection with cellular methyl-donor balance and nicotinamide metabolism. Published work on 5-Amino-1MQ includes enzyme inhibition, cell-based experiments and studies in mice.
5-Amino-1MQ belongs to small-molecule research and has no amino-acid sequence of the kind used to identify a peptide. The cited findings are preclinical; they do not establish a weight-loss or performance benefit in people.
Strength and packs
One vial contains 10 mg. Two vials contain 20 mg total, and three vials contain 30 mg total. Every vial in each pack contains the same 10 mg strength.
Choose pack count according to the number of individually supplied vials required for the research inventory.
Scientific sources
Selective and membrane-permeable small molecule inhibitors of NNMT
Small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT).
Every batch is analyzed by an independent laboratory via HPLC before shipment. We document purity (avg. 99.43% in 2026), mass spectrometry identity, and sterility. Production follows GMP standards in ISO-certified laboratories.